| Guendolyn Comeque Logronio, | |
|
5761 Buckingham Pkwy, Culver City, CA 90230-6515 | |
| (310) 649-6199 | |
| Not Available |
| Full Name | Guendolyn Comeque Logronio |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 5761 Buckingham Pkwy, Culver City, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376307074 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 18857 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Guendolyn Comeque Logronio, 5761 Buckingham Pkwy, Culver City, CA 90230-6515 Ph: (310) 649-6199 | Guendolyn Comeque Logronio, 5761 Buckingham Pkwy, Culver City, CA 90230-6515 Ph: (310) 649-6199 |
News Archive
Spectrum Pharmaceuticals, a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced that the United States Patent and Trademark Office (USPTO) has extended by five years the U.S. Patent No. 6,028,071, which covers FOLOTYN (pralatrexate injection).
Individuals with brain injury and their families often struggle to accept the associated personality changes. The behavior of individuals with acquired brain injury (ABI) is typically associated with problems such as aggression, agitation, non-compliance, and depression. Treatment goals often focus on changing the individual's behavior, frequently using consequence-based procedures or medication. In the current issue of NeuroRehabilitation leading researchers challenge this approach and recommend moving emphasis from dysfunction to competence.
A University of California - San Francisco (UCSF) study has found that a specific signaling link between neurons and muscles in the fruit fly is essential for keeping the insect's nervous system stable.
Mymetics Corporation, a pioneer in the research and development of virosome-based vaccines to prevent transmission of human infectious diseases across mucosal membranes, announced today that its innovative HIV vaccine candidate will enter a new preclinical trial to confirm excellent results obtained in a previous trial.
Combination therapies similar to those used for HIV patients may be the best way of treating hepatitis C virus (HCV), say researchers from the University of Leeds.
› Verified 1 days ago
Belinda Williams, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5761 Buckingham Pkwy, Culver City, CA 90230 Phone: 310-649-6199 | |
Miss Angela Jean Adley, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 11825 Major St, Culver City, CA 90230 Phone: 310-915-6100 | |
Diane Bernstein, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5761 Buckingham Pkwy, Culver City, CA 90230 Phone: 310-649-6199 | |
Regina Del Carmen, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5761 Buckingham Pkwy, Culver City, CA 90230 Phone: 310-649-6199 | |
Jennifer Nelly Razo, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6820 S Centinela Ave, Culver City, CA 90230 Phone: 310-337-7115 | |
Haley Marie St. Martin, MS Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5901 Green Valley Cir Ste 130, Culver City, CA 90230 Phone: 858-254-4840 | |
Cheyanne Pi Ling Chen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6059 Bristol Pkwy, #100, Culver City, CA 90230 Phone: 866-278-1520 |